首页> 外文期刊>Southern African Journal of Gynaecological Oncology >Discrepancy between preoperative endometrial sampling and hysterectomy diagnosis in endometrial cancer
【24h】

Discrepancy between preoperative endometrial sampling and hysterectomy diagnosis in endometrial cancer

机译:子宫内膜癌术前子宫内膜采样和子宫切除诊断的差异

获取原文
获取外文期刊封面目录资料

摘要

Background: A study was conducted to determine the accuracy of preoperative endometrial sampling histology type and tumour grade results compared with the final postoperative diagnosis. Methods: This was a retrospective chart audit of patients with endometrial cancer and atypical hyperplasia admitted to Grey’s Hospital in Pietermaritzburg, South Africa, from January 2013 to December 2017. Results: Sixty patients met the inclusion criteria. For endometrial cancer histological types, the accuracy of preoperative endometrial sampling was 94.7% (36/38) for endometrioid adenocarcinoma, 42.9% (3/7) for serous papillary carcinoma, 85.7% (6/7) for carcinosarcoma and 75% (9/12) for atypical hyperplasia. A kappa value of 0.825 was obtained with a p -value of 0.000 for agreement between preoperative endometrial sampling and the final postoperative diagnosis. For endometrioid?adenocarcinoma tumour grading 1–3 (G1–3), only 16/38 (42.1%) patients met the criteria to compare the pre- and?postoperative results, which were as follows: of the eight patients with grade 1 tumour on preoperative sampling one?patient (1.25%) was upgraded to grade 2 tumour postoperatively. There were no changes in tumour grading for grade 2 and 3 tumours, 3/3 and 5/5 respectively. Conclusion: Our study results for endometrioid adenocarcinoma are comparable to previous literature. However, there were significant discrepancies for non-endometrioid adenocarcinoma. Deficiencies that need to be addressed by laboratories in order to improve both preoperative surgical staging and postoperative adjuvant therapy planning were also highlighted.
机译:背景:与最终术后诊断相比,进行了一项研究以确定术前子宫内膜采样组织学类型和肿瘤级结果的准确性。方法:这是从2013年1月到2017年1月到2017年1月到2017年12月,南非彼得曼朱茨堡的子宫内膜癌和非典型增生患者的回顾录审计。结果:六十名患者达到了纳入标准。对于子宫内膜癌组织学类型,术前子宫内膜取样的准确性为子宫内膜腺癌的94.7%(36/38),42.9%(3/7),用于乳粉状癌的85.7%(6/7),75%(9 / 12)对于非典型增生。在术前子宫内膜抽样和最终术后诊断之间,使用0.825的Kappa值为0.825。对于子宫内瘤?腺癌肿瘤分级1-3(G1-3),只有16/38(42.1%)患者达到比较预期和?术后结果的标准,如下:八级肿瘤患者的患者在术前取样一个?患者(1.25%)术后升级至2级肿瘤。 2级和3级肿瘤,3/3和5/5的肿瘤分级没有变化。结论:我们对EndoMetroI中腺癌的研究结果与先前的文献相当。然而,非胚胎腺癌具有显着的差异。还强调了实验室需要由实验室解决的缺陷,以改善术前手术分期和术后辅助治疗计划。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号